Latent Inhibition & Schizophrenia Flashcards
Schizophrenia background
Schizophrenia is a serious mental disorder, characterised by hallucinations and delusions
Dopamine (DA) is implicated based on evidence that
(1)DA agonists can induce schizophrenic-like symptoms
(2)Schizophrenia is treated with DA antagonists
Better drugs are needed to treat SZ
- Cases worldwide: 24 million
- Lifetime risk: 2-10 per 1000
- Poor prognosis (< 25% recover; 20-30% don’t respond at all to existing drugs)
- Existing drugs mostly ineffective for negative symptoms
- Unacceptable incidence and severity of side effects
- Suicide risk: 10%, 25% sufferers attempt
Cognitive and attentional problems in SZ
- “The basic cognitive defect… is an awareness of automatic processes which are normally carried out below the level of consciousness” (Frith, 1979)
- Schizophrenics show a “failure of attentional focusing to respond to stimulus redundancy” (Maher, 1983)
- “Schizophrenics are less able to make use of the redundancy and patterning of sensory input” (Hemsley, 1987)
- Schizophrenics “concentrate on detail at the expense of theme” (Cutting, 1985)
Amphetamine psychosis (Griffith et al. ,1972)
Participants (n = 7) users but no prior history of psychosis
Given 10 mg dextroamphetamine every hour for up to 5 days
All became psychotic within 2-5 days
Delusions mostly auditory, also included poisoning by experimenters and electric dynamo thought control
Pro- and anti-psychotic drug actions
Amphetamine is psychotomimetic
Amphetamine is an indirect dopamine (DA) agonist
Typical antipsychotics are DA D2 antagonists (e.g. haloperidol)
Atypical antipsychotics have different DA D2 affinity, block also D4 and 5-HT2
D1 agonists to boost DA hypo-function in frontal cortex? (Goldman-Rakic, 2004)
How the model came about and continues to develop…
Better drugs are needed for schizophrenia (SZ)
SZ is characterised by attentional problems, some of which can be measured in animals
Amphetamine is a drug model for SZ
LI is impaired in SZ and by amphetamine
Model extends to studies of individual differences (psychoticism, schizotypy)
Rat model is now used to identify neural substrates
Effects on LI are compared to those seen using other methods to weaken associative learning
Latent inhibition (LI)
Pre-exposure (PE) Control (NPE)
Stage 1: CSa->nothing [CSb->] nothing
Stage 2: CSa->US CSa->US
Stimulus pre-exposure (in stage 1) reduces later learning (in stage 2) when the stimulus is now relevant
LI can apply to both excitatory and inhibitory stimuli, i.e. LI of a potential inhibitor
Basic experimental design for LI
- Degree of LI assessed by comparing learning in PE and NPE groups
- Follow-up test of associative learning
- Experimental effects (of drug or lesion treatments or in different patient populations) can be measured in 2 x 2 designs
- Degree of LI is assessed by comparing PE and NPE groups in each experimental condition
- Comparing NPE groups to determine effects on conditioning
LI in rats is abolished under amphetamine
Suppression ratio
0.5 = no learning
Testing for LI in human participants
- Methods first developed in Lubow’s laboratory
- Task should not be too obvious
- US = counter increment
- Task to work out which of a series of nonsense syllables (e.g., pev, jic) predicts the counter increment
- CS in fact a white noise
. LI deficits in participants with SZ
- Link between the loss of LI and SZ shown using the counter increment variant (Baruch et al., 1988)
- LI is reduced or abolished in acute (but not chronic) SZ
- Since the failure of LI is expressed as a relative learning increase, it can’t be due to non-specific features of the disease process
Translational evidence
•Amphetamine treatment abolishes LI in ‘normal’ human participants
(single 5 mg dose, Gray et al., 1996)
•Haloperidol can reduce LI in humans (Williams et al., 1997, 1998)
•But any beneficial effect might be expected to depend on baseline DA activity
•Haloperidol effects in healthy humans depend on Psychoticism scores
(single 5 mg dose, Kumari et al., 1999)
Haloperidol effects depend on P
Kumari et al 1999
Measuring schizotypy in normal participants (O-LIFE)
- Are the sounds you hear in your daydreams really clear and distinct?
- Do your thoughts sometimes seem as real as actual events in your life?
- Does it often happen that nearly every thought immediately and automatically suggests an enormous number of ideas?
- Do you believe in telepathy?
- Are your thoughts sometimes so strong that you can almost hear them?
- Do your thoughts ever stop suddenly causing you to interrupt what you are saying?
- Do you think you could learn to read others’ minds if you wanted to?
LI reduced with schizotypy
Shrira & Kaplan, 2009 Two procedures (1) without masking and (2) with masking